Background
Alport syndrome is an inherited renal disease caused by mutations in
COL4A3
,
COL4A4,
or
COL4A5
genes. Coexisting mutations in either two of the three genes in Alport patients have been reported recently. However, the effect of heterozygous mutations in
COL4A3
or
COL4A4
genes in X‐linked Alport syndrome (XLAS) patients is unclear.
Methods
Using targeted next‐generation sequencing, six unrelated Chinese children were identified to have a combination of a pathogenic variant in
COL4A5
and a heterozygous mutation in
COL4A3
or
COL4A4
. They were three males and three females. Another three XLAS males each with only one pathogenic variant in
COL4A5
were included. The clinical data were analyzed and compared between the males in two groups (group 1, males with a pathogenic variant in
COL4A5
and a heterozygous pathogenic variant in
COL4A3
or
COL4A4
; group 2, males with only one pathogenic variant in
COL4A5
).
Results
Patients with XLAS who also had heterozygous pathogenic
COL4A3
or
COL4A4
variants accounted for 1% of Alport syndrome. In this study, three children showed coexisting pathogenic variants in
COL4A5
and
COL4A3
. Two children showed pathogenic variants in
COL4A5
and
COL4A4
. One child had pathogenic variants in the three
COL4A3‐5
genes, in which the pathogenic variant in
COL4A5
was de novo and the pathogenic variants in
COL4A4
and
COL4A3
were inherited independently (in trans). The site and type of mutations in
COL4A5
were similar between the two groups. It was revealed that males in group 1 presented more severe proteinuria than males in group 2 (
p < 0.05
).
Conclusion
The present study provides further evidence for complicated genotype in Alport syndrome. For the first time, we reported a case with three pathogenic variants in
COL4A5
,
COL4A3
, and
COL4A4
genes. Moreover, we found that heterozygous pathogenic
COL4A3
or
COL4A4
variants are likely to make XLAS disease more serious.